Surgical Treatment with Locoregional Flap for the Nose

Table 1

Patients characteristics, cancer histological type, and recurrence rate are reported. The table summarizes the localization of the lesions and relate it with the correspondent reconstructive option and locoregional flap. Postoperative surgical complications rate are pointed out.

Patients	Localization	Locoregional flap	Complications
(i) Number of patients: 310; (ii) Male: 203 (65.48%); (iii) Female: 107 (34,52%); (iv) Age: years (range 40–88 y)	Proximal third area; (22,9%)	(i) Miter (dorsonasal) Flap (28,2%); (ii) Glabellar flap (45,1%); (iii) Rotation flap (18,3%); (iv) Others (8,5%)	Complications requiring revisions; Number of patients: 7 (2,3%); (i) Partial flap necrosis; (ii) Dehiscence of the wound/donor site
NMSC histological type; (i) Basal cell carcinoma (BCC): 195 (62,9%); (ii) Squamous cell carcinoma (SCC): 115 (37.1%)	Middle third area; (18,1%)	(i) Miter (dorsonasal) flap (26,79%); (ii) Nasolabial flap (21,43%); (iii) V-Y advancement flap (25%); (iv) Rotation flap (17,9%); (v) Others (8,9%)	General complications: Number of patients: 9 (2,9%); (i) Infection; (ii) Hematoma
Cancer recurrence rate; (i) Number of patients: 5; (1,6%)	Distal third area; (40,6%)	(i) Miter (dorsonasal) flap (16,7%); (ii) Nasolabial flap (27%); (iii) V-Y advancement flap (14,3%); (iv) Rotation flap (16,6%); (v) Bilobed flap (24,6%); (vi) Others (0,8%)
	Complex defects; (involving more than 1 subunit); (18,3%)	(i) Forehead flap (63,1%); (ii) Nasolabial flap (21,1%); (iii) V-Y flap (15,7%)